歡迎光臨 國立中央大學生醫科學與工程學系

專長：頭頸腫瘤微環境、癌症放射治療抗性機轉、EB病毒與鼻咽癌、腫瘤免疫學
連絡電話：03-4227151轉27768
E-mail：jennyliu66@gmail.com

Education (學歷):
2009   Ph.D.    Institute of Life Science (Academia Sinica/National Defense Medical Center/National Health Research Institutes, Taiwan)
2000   M.S    Radiological Sciences, National Yang-Ming University, Taiwan
 
Research experiences (學術經歷):
2022/8－present Associate professor (Department of Biomedical Sciences and Engineering, National Central University, Taiwan)
2016－2022/7      Assistant professor (Department of Biomedical Sciences and Engineering, National Central University, Taiwan)
2015－2016/01   Assistant research scholar (Department of Biomedical Sciences and Engineering, National Central University, Taiwan)
2009－2015         Postdoctoral research fellow (Molecular Medicine Research  Center, Chang Gung University, Taiwan)
 
Professional Memeberships:
Taiwan Society for Therapeutic Radiology and Oncology (台灣放射腫瘤學會)
The Taiwan Oncology Society  (中華民國癌症醫學會)
 
Lab Research Interests (實驗室研究主題)
-Tumor microenvironment (腫瘤微環境)
-Molecular mechanisms of HNSCC progression (頭頸癌惡性化機轉)
-Tumor single cell genomics (癌組織單細胞基因體研究)
-Immuno-Oncology (腫瘤免疫學)
- Epstein-Barr virus-associated carcinogenesis (EB病毒相關惡性腫瘤)
- Radiation oncology (放射腫瘤學)

研究計畫(Grants)
1.探索以LIF及LIFR為標靶的頭頸腫瘤免疫輔助治療潛能與抑制劑開發 (國科會，2023/08/01~2026/07/31，主持人) 。
2.以CRISPR/Cas9全基因體策略解讀Orf病毒在鼻咽癌誘導溶瘤的細胞決定因子(國科會，2024/08/01~2025/07/31，共同主持人)
3.利用已建立的單細胞定序技術資料庫來探索口腔癌新穎的生物標識及相關分子傳導路徑 (國科會，2022/08/01~2025/07/31，共同主持人) 。
4.腫瘤微環境癌細胞與免疫因子的對話(科技部, 2021/08/01~2022/07/31; 共同主持人) 。
5.白血病抑制因子於口腔鱗狀上皮細胞癌的免疫調控機制(109-2314-B-008-001-MY3) (科技部, 2020/08/01~2023/07/31; 主持人) 。
6.具深度學習之超高像素顯微術於活細胞抗癌藥物治療之高通量動態影像分析系統研製(科技部, 2020/08/01~2022/07/31, 共同主持人) 。
7.含EBV病毒產物之外吐小體對鼻咽癌細胞及微環境基質細胞的調控-II (科技部 108-2314-B-008-003-)(主持人)。
8.榮台聯大整合型研究計畫 (VGHUST108-G4-3-1, 2019/1/1~2019/12/31, 主持人) 。
9.含EBV病毒產物之外吐小體對鼻咽癌細胞及微環境基質細胞的調控(科技部 107-2314-B-008-003-)(主持人)。
10.榮台聯大整合型研究計畫(VGHUST107-G4-2-1, 2018/1/1~2018/12/31, 主持人) 。
11.科技部延攬研究學者計畫(2015/08/01~2018/07/31): EBV病毒調控脂肪細胞分化並重建腫瘤微環境 (MOST -104-2321-B-008-003-MY3)(主持人)。
12.國際科技人士短期訪問計畫(計畫編號：106WCSFA0700029)(國立中央大學生醫科學與工程學系主辦「2017 生物醫學工程科技研討會」暨「科技部醫學工程學門成果發表會」。
13.榮台聯大整合型研究計畫(VGHUST106-G4-2-1, 2017/1/1~2017/12/31, 主持人) 。
 
專利與技術報告 (Patents & technical reports)
1.Potentiation of nasopharyngeal cancer radiotherapy by inhibitors of leukemia inhibitory factor  (美國)( US9,194,872 B2; 專利期限2015/11 至2034/04)。
2.評估癌症於治療後情況的方法及其相關應用 (中國)( CN 104623663 A; 專利期限2017 /7/14至2034/1/26)
3.鼻咽癌治療的醫藥  (台灣，發明第I486172，專利期間: 2015/06~2033/11)。
4.人類口腔癌細胞株NCU-OC1 (human oral cancer cell line NCU-OC1)(申請中)。
 
獎項 (Honors)
-中央大學112學年度(2023)學術研究傑出獎(Outstanding Research Award, National Central University, Taiwan) 
- (2023)第二十七屆台灣癌症聯合學術年會優秀論文獎(The 27th Taiwan Joint Cancer Conference Award)(Fist & Corresponding author)
-中央大學111學年度(2022)學術研究傑出獎(Outstanding Research Award, National Central University, Taiwan) 
-第18屆(2022)榮總台灣聯合大學合作研究計畫優良論文獎第一名 (Outstanding Paper Award, the First Place. The Veterans General Hospitals and University System of Taiwan Joint Research)
- 中央大學110學年度(2021)學術研究傑出獎(Outstanding Research Award, National Central University, Taiwan)

期刊論文
-- Shu-Chen Liu*, Chun-I Wang, Tzu-Tung Liu, Ngan-Ming Tsang, Yun-Hua Sui, Jyh-Lyh Juang*. A 3-gene signature comprising CDH4, STAT4 and EBV-encoded LMP1 for early diagnosis and predicting disease progression of nasopharyngeal carcinoma. Discover Oncology (2023)14:119. 

-- Yun Hua Sui, Tzu Tung Liu, Shu Chen Liu. Leukemia inhibitory factor regulates macrophage immune response in head and neck squamous cell carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5968.

-- Tzu-Tung Liu, Yun-Hua Sui, Fang-Yu Tsai, Shih-Sheng Jiang, Kai-Ping Chang, Chen-Han Huang, Shu-Chen Liu. EBV positive NPC-derived exosomes promote macrophage M2 polarization via activating MST1R and YAP1 signalings [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2500.

--Po-Ju Lee, Yun-Hua Sui, Tzu-Tung Liu, Ngan-Ming Tsang, Chen-Han Huang, Ting-Yi Lin, Kai-Ping Chang*, Shu-Chen Liu* Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts. Journal of Experimental & Clinical Cancer Research 2022 Aug 20;41(1):254. doi: 10.1186/s13046-022-02456-5. PMID: 35986369. (IF: 12.66) (corresponding author). 

--Shu-Chen Liu*, Ngan-Ming Tsang, Po-Ju Lee, Yun-Hua Sui, Chen-Han Huang and Tzu-Tung Liu (2021, Apr). Epstein-Barr virus induces adipocyte dedifferentiation to modulate the tumor microenvironment. Cancer Research, 2021 Apr 6; doi: 10.1158/0008-5472. (IF: 12.7) (the first & corresponding author)

--Ting-Wen Chen, Kai-Ping Chang, Chun-Chia Cheng, Cheng-Yi Chen, Shu-Wen Hong, Zong-Lin Sie, Hsing-Wen Cheng, Wei-Chen Yen, Yenlin Huang, Shu-Chen Liu*, and Chun-I Wang*. Characterization of Recurrent Relevant Genes Reveals a Novel Role of RPL36A in Radioresistant Oral Squamous Cell Carcinoma. Cancers 2021, 13(22), 5623. (IF: 6.575) (corresponding author).

--Shu-Chen Liu*, Tien Hsu , Yu-Sun Chang, An-Ko Chung, Shih Sheng Jiang, Chun-Nan OuYang, Chiou-Hwa Yuh, Chuen Hsueh, Ya-Ping Liu, Ngan-Ming Tsang*. Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK/PXN signaling. Nature communications, (2018) 9: 5105. (IF: 17.694) (the first & corresponding author)

--Mai-Huong Thi Nguyen, Chen-Huan Lin, Szu-Mam Liu, Azusa Miyashita, Hironobu Ihn, Hsuan Lin, Chi Hou Ng, Jen-Chieh Tsai, Ming-Hong Chen ,Mu-Shiun Tsai, In-Yu Lin, Shu-Chen Liu, Long-Yuan Li, Satoshi Fukushima, Jean Lu, Nianhan Ma* (2020, Dec). miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma. Neoplasia, 2020 Dec;22(12):789-799. (IF:6.218).

--Zong-Lin Sie, Ruei-Yang Li, Bonifasius Putera Sampurna, Po-Jui Hsu, Shu-Chen Liu, Horng-Dar Wang, Chou-Long Huang, and Chiou-Hwa Yuh* (2020, Mar). WNK1 Kinase Stimulates Angiogenesis to Promote Tumor Growth and Metastasis. Cancers, 12(3), 575. (IF: 6.575).

--Wen Ching Chuang, Ngan Ming Tsang, Chi Cheng Chuang, Kai Ping Chang, Ping Ching Pai, Kuan Hung Chen, Wen Chi Chou, Shiao Fwu Tai, Shu Chen Liu, Kin Fong Lei* (2020, Jan). Association of subcutaneous and visceral adipose tissue with overall survival in Taiwanese patients with bone metastases – results from a retrospective analysis of consecutively collected data. Plos one, 15(1):e0228360. (IF: 3.752).

--Kuan-Hung Chen, Ngan-Ming Tsang, Wen-Chi Chou, Shiao Fwu Tai, Shu-Chen Liu, Kin-Fong Lei, Kai-Ping Chang, Wen-Ching Chuang, Ping-Ching Pai* (2019, May). Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in older patients with metastatic cancer. Journal of Geriatric Oncology, 2019 May 10. pii: S1879-4068(19)30040-2. (IF: 3.929).

--Ji-Lin Jou, Shu-Chen Liu and Lin I *(2019, May). Tail shape evolution dynamics of MDCK cells on fibronectin substrates. Biomedical Physics & Engineering Express, 2019 (5) 045001. (IF: 1.291, Ranking: 163/229, Biomedical Engineering).
 
--Hsiang-Ying Chen, Yi-Teng Hsiao, Shu-Chen Liu , Tien Hsu, Wei-Yen Woon, Lin I *. Enhancing Cancer Cell Collective Motion and Speeding up Confluent Endothelial Dynamics through Cancer Cell Invasion and Aggregation. Physical Review Letters. 2018, 121(1): 01810. (IF: 9.185). 

--Tzong-Shoon Wu1, Lian-Chen Wang1, Shu-Chen Liu1, Ting-Yu Hsu, Chun-Yen Lin, Gou-Jin Feng, Jian-Ming Chen, Hao-Ping Liu, I-Che Chung, Tzu-Chen Yen, Yu-Sun Chang, Shuen-Kuei Liao, Chen Chang, Kai-Ping N Chow*. EBV oncogene N-LMP1 induces CD4 T cell-mediated angiogenic blockade in the murine tumor model.J Immunol. 2015 May 1;194(9):4577-87 (1co-first author) (highlight article, IF: 5.422).

--Shu-Chen Liu and Yu-Sun Chang. Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis. Molecular & Cellular Oncology. 2014 Jul 15 1(1): e29900. (first author)

--Chia-Wei Hsu, Jau-Song Yu, Pei-Hua Peng, Shu-Chen Liu, Yu-Sun Chang, Kai-Ping Chang, Chih-Ching Wu. Secretomic profiling of primary cells reveals that THBS2 is a salivar biomarker of oral cavity squamous cell carcinoma. J Proteome Res. 2014 Nov 7;13(11):4796-807. (IF: 4.268)

--Shu-Chen Liu, Ngan-Ming Tsang, Wen-Che Chiang, Kai-Ping Chang, Chuen Hsueh, Ying Liang, Jyh-Lyh Juang, Kai-Ping N Chow, Yu-Sun Chang*Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest. 2013 Dec 2;123(12):5269-83 (IF:14.808, highlight article) (first author).

--Hao-Ping Liu, Chia-Chun Chen, Chih-Ching Wu, Yi-Chuan Huang, Shu-Chen Liu, Ying Liang, Kai-Ping Chang, Yu-Sun Chang. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells. PLoS Pathog. 2012 May;8(5): e1002690 (IF: 6.608)

--Pei-Hua Peng, Chih-Ching Wu, Shu-Chen Liu, Kai-Ping Chang, Chi-De Chen, Ya-Ting Chang, Chia-Wei Hsu, Yu-Sun Chang, Jau-Song Yu. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics. 2011 May 1;74(5):744-57. (IF: 3.914)

--Hsin-Chien Chen , Hsin-I Ma, Huey-Kang Sytwu, Hsing-Won Wang, Chia-Chi V Chen, Shu-Chen Liu, Chi-Huang Chen, Hang-Kang Chen, Chih-Hung Wang. Neural stem cells secrete factors that promote auditory cell proliferation via a leukemia inhibitory factor signaling pathway. J Neurosci Res. 2010 Nov 15;88(15):3308-18. (IF: 4.164)

--Shu-Chen Liu, Yee-Min Jen, Shih Sheng Jiang, Junn-Liang Chang, Chao A Hsiung, Chih-Hung Wang, Jyh-Lyh Juang. G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. Cancer Research. 2009 Aug 1;69(15):6122-30 (IF: 12.7) (first author)

--Chi-Chung Wen, Shu-Chen Liu, Li-Chu Chien, Chung-Yen Lin, Chao A Hsiung, Jyh-Lyh Juang. Temporal transcription program of recombinant Autographa californica multiple nucleopolyhedrosis virus. J Virol. 2006 Sep; 80(18):8989-99. (IF: 5.103).

--Chi-Chung Wen , Yuh-Jenn Wu, Yung-Hsiang Huang, Wei-Chen Chen, Shu-Chen Liu, Shih Sheng Jiang, Jyh-Lyh Juang, Chung-Yen Lin, Wen-Tsen Fang, Chao Agnes Hsiung, I-Shou Chang. A Bayes regression approach to array-CGH data. Stat Appl Genet Mol Biol. 2006;5: Article3. (IF: 1.055)
 
學生成果表現
-隋昀華:(2024) The 1st Taiwan-Korea Radiation Oncology Symposium & 2024 Joint Annual Scientific Meeting of TASTRO and CSMPT (第一屆台韓放腫交流會議暨2024台灣放射腫瘤學會及中華民國醫學物理學會聯合學術研討會, 臨床含基礎論文口頭競賽 第三名)
-劉子彤:(2024) Taiwan-Korea Radiation Oncology Symposium (2024 TKROS) Oral Presentation Award - First Place (第一屆台韓放腫交流會議暨2024台灣放射腫瘤學會及中華民國醫學物理學會聯合學術研討會, 臨床含基礎論文口頭競賽 第一名)
-隋昀華:(2024) The 27th Taiwan Joint Cancer Conference Award (第二十八屆台灣癌症聯合學術年會優等論文獎)
-劉子彤:(2024) The 28th Taiwan Joint Cancer Conference Award (第二十八屆台灣癌症聯合學術年會優秀論文獎) 
-劉子彤:(2023) The 27th Taiwan Joint Cancer Conference Award (第二十七屆台灣癌症聯合學術年會優秀論文獎) 
-隋昀華: (2023)獲國科會研究生出席國際會議補助(美國癌症研究年會; AACR) 
-劉子彤: (2023)獲國科會研究生出席國際會議補助(美國癌症研究年會; AACR)
-劉子彤:第37屆(2023)生物醫學聯合學術會議 永信李天德醫藥基金會壁報論文優等獎
-劉子彤: 獲選2023福爾摩沙免疫春季學校學員(2023) Formosa Immunology Spring School & Symposium (福爾摩沙免疫春季學校與會議)
-孫克文(大四): 錄取TIGP博士學程。
-劉子彤:第22屆亞太區醫學物理學會國際學術研討會 最佳口頭論文報告獎.
-隋昀華:111學年度第二學期中央大學優秀學生獎學金。
-劉子彤:111學年度第一學期中央大學優秀學生獎學金。
-李孟昕: FISS 2022 Symposium Program 福爾摩沙春季免疫學校會議。
-李孟昕: 2022第一屆台灣粒子治療國際高峰會議。
-孫克文: 獲科技部111年度大專生研究計畫(Investigating the LIF-mediated metabolic regulation in tumor-associated macrophages)。
-孫克文: 2022中央研究院分子生物研究所暑期大專生研習計畫。
-孫克文: FISS 2022 Symposium Program 福爾摩沙春季免疫學校會議。
-陳璿仲: 2022中央研究院分子生物研究所暑期大專生研習計畫。
-陳璿仲: FISS 2022 Symposium Program 福爾摩沙春季免疫學校會議。
-陳璿仲: 2022第一屆台灣粒子治療國際高峰會議。
-李柏儒(畢業)、隋昀華、劉子彤:國際期刊共同作者 (J Exp Clin Cancer Res. 2022 Aug 20;41(1):254.)
-李柏儒:第二十五屆(2021)台灣癌症聯合學術年會(TJCC)優秀論文獎。
-李柏儒、隋昀華、劉子彤:國際期刊共同作者 (Cancer Research, 2021 Apr 6;  doi: 10.1158/0008-5472) 。
-隋昀華:Outstanding Award - Industrial Development Bureau Digi+ X TCA Global Talent Award, Taipei, Taiwan. (工業局Digi+ X TCA 全球數位新星大賞, 2021, 12/07).
-隋昀華:國衛院110年度Digi talent精準醫療產業發展–基因檢測大數據分析研習(DIGI+Talent 跨域數位人才加速躍升計畫) 。
-劉子彤:Outstanding Award - 2021 Industrial Development Bureau. Ministry of Economic Affairs "DIGI+ X TCA Global Talent Award" (2021 經濟部工業局 DIGI+ X TCA 全球數位新星大賞/特選）
-劉子彤:通過中央研究院基因體研究中心與中央大學生醫理工學院研究生培育計畫獎助。
-劉子彤: 2021 國立中央大學生醫理工學院 生命科學暨醫療科技研究成果全英語口頭發表競賽/碩博組第三名。
-劉子彤:國衛院110年度Digi talent精準醫療產業發展–基因檢測大數據分析研習(DIGI+Talent 跨域數位人才加速躍升計畫) 。
-隋昀華:2021通過中央研究院基因體研究中心與中央大學生醫理工學院研究生培育計畫獎助。
-隋昀華:2021 國立中央大學生醫理工學院 繪畫創作競賽 第二名。
-李柏儒:109學年度第一學期中央大學優秀學生獎學金。
-李柏儒:日本熊本大學癌症生物實驗室實習(2020/3~2020/8) 。
-李柏儒:獲科技部研究生出席國際會議補助(109-2922-1-008-018): EACR-AACR-ASPIC ‘Basic and Translational Research Conference Tumor Microenvironment, Lisbon Portugal.
-隋昀華:109學年度第一學期 中央大學優秀學生獎學金。
-隋昀華:109年度生醫系大學生專題研究成果報告比賽第二名。
-隋昀華:科技部109年度大專生研究計畫(計畫編號：109-2813-C-008-034-B) 。
-劉子彤:109學年度第一學期 中央大學優秀學生獎學金。
-劉子彤: (2020)國家衛生研究院大專生成果報告評鑑”優選” 。
-劉子彤:109年度生醫系大學生專題研究成果報告比賽佳作。
-劉子彤:國家衛生研究院大專生研習計畫(2020/7) 。
-劉子彤:科技部109年度大專生研究計畫(計畫編號：109-2813-C-008-033-B) 。
-隋昀華:2020中央大學生醫理工學院繪畫創作比賽第三名。
-李心慈:科技部110年度大專生研究計畫(初代口腔癌細胞對自然殺手細胞的防禦機制探討)。
-李心慈: 中研院生醫所暑期實習(2020/7~2020/9) 。
-邱子筠: 中研院生醫所暑期實習(2020/7~2020/9) 。
-李柏儒:2019斐陶斐榮譽學會會員。
-隋昀華:中研院生醫所暑期實習(2019/7~2019/9) 。
-隋昀華:2019(高雄醫學院主辦)醫材輔具健康福祉講座交流競賽佳作。
-隋昀華:2019中央大學生醫理工學院繪畫創作比賽第二名及佳作。
-隋昀華:國立中央大學108學年度第二學期中央大學優秀學生獎學金。
-隋昀華:108 生醫科學與工程學系第一學期書卷獎。
-隋昀華:108 生醫科學與工程學系第二學期書卷獎。
-隋昀華:2018(成功大學主辦)生技醫材設計與開發學分班&次世代醫療器材新創開發戰鬥營第二名。
-劉子彤:劉子彤:中研院生醫所暑期實習(2019/7~2019/9) 。
-劉子彤:劉子彤:2018中央大學全校運動會兩千五百公尺女子組第一名;八百公尺女子組第二名。
-李柏儒:國立中央大學107學年度第一學期中央大學優秀學生獎學金。
-李柏儒:獲科技部107年度大專生研究計畫(計畫編號：107-2813-C-008-059-B) 。
-李柏儒:中研院生醫所暑期實習(2017/7~2017/9)。

學生會議論文(2018~今)
-Tzu-Tung Liu, Kai-Ping Chang, Ngan-Ming Tsang, Fang-Yu Tsai, Shih-Sheng
Jiang, Shu-Chen Liu* (2024, Aug). Deciphering the Systemic Immune Responses Mediated by Radiotherapy in Stage I NPC Patients. 2024 Taiwan-Korea Radiation Oncology Symposium (Oral Presentation Award - First Place) (第一屆台韓放腫交流會議暨2024台灣放射腫瘤學會及中華民國醫學物理學會聯合學術研討會, 臨床含基礎論文口頭競賽 第一名).
-Yun-hua Sui, Tzu-tung Liu, Kai-ping Chang, Shu-chen Liu*. LIF-Mediated Immunosuppressive Macrophage Response via YAP1 Activation in Nasopharyngeal Carcinoma (The 1st Taiwan-Korea Radiation Oncology Symposium & 2024 Joint Annual Scientific Meeting of TASTRO and CSMPT (第一屆台韓放腫交流會議暨2024台灣放射腫瘤學會及中華民國醫學物理學會聯合學術研討會, 臨床含基礎論文口頭競賽 第三名).
-Tzu-Tung Liu, Kai-Ping Chang, Ngan-Ming Tsang, Fang-Yu Tsai, Shih-Sheng
Jiang, Shu-Chen Liu* (2024, May). Radiotherapy-mediated immune modulatory
responses in patients with stage I nasopharyngeal carcinoma (2024 /5/4~/5/5, The 28th Taiwan Joint Cancer Conference, 第二十八屆台灣癌症聯合學術年會論文競賽優良獎). 
-Yun-Hua Sui, Tzu-Tung Liu, Kai-Ping Chang,Shu-Chen Liu* (2024, May). Leukemia inhibitory factor-YAP1 axis-mediated macrophage immunosuppression in oral squamous cell carcinoma (2024 /5/4~/5/5, The 28th Taiwan Joint Cancer Conference, 第二十八屆台灣癌症聯合學術年會基轉組論文競賽優等獎). 
-Hsuan-Chung Chen(陳璿仲) , Yun-Hua Sui , Tzu-Tung Liu , Shu-Chen Liu* Investigating the Role of Leukemia Inhibitory Factor Receptor in Cancer Stemness of Oral Squamous Cell Carcinoma. (2023/11/10-11/12, The Taiwan Society for Biochemistry And Molecular Biology and Taiwan Oncology Society Joint Meeting, 2023生化秋令營暨免疫腫瘤轉譯研究研討會)
-Meng-Hsin Lee(李孟昕), Yun-Hua Sui, Tzu-Tung Liu, Shu-Chen Liu* Investigating the Role of Leukemia Inhibitory Factor in Regulating Function of Mast Cells in Oral Squamous Cell Carcinoma. (2023/11/10-11/12, The Taiwan Society for Biochemistry And Molecular Biology and Taiwan Oncology Society Joint Meeting, 2023生化秋令營暨免疫腫瘤轉譯研究研討會)
-Tzu-Tung Liu (劉子彤), Yun-Hua Sui1, Ngan-Ming Tsang, Kai-Ping Chang, Shih-Sheng Jiang, Fang- Yu Tsai, Chen-Han Huang, Shu-Chen Liu* Nasopharyngeal Carcinoma-Derived Exosomes Facilitate Immunosuppressive Macrophage Polarization via Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (2023/11/10-11/12, The Taiwan Society for Biochemistry And Molecular Biology and Taiwan Oncology Society Joint Meeting, 2023生化秋令營暨免疫腫瘤轉譯研究研討會)
-Yun-Hua Sui (隋昀華), Tzu-Tung Liu, Kai-Ping Chang, Shu-Chen Liu* Leukemia Inhibitory Factor Promotes Macrophage Immunosuppressive Function in Oral Squamous Cell Carcinoma through YAP1 Activation. (2023/11/10-11/12, The Taiwan Society for Biochemistry And Molecular Biology and Taiwan Oncology Society Joint Meeting, 2023生化秋令營暨免疫腫瘤轉譯研究研討會)
-Yun-Hua Sui (隋昀華), Tzu-Tung Liu, and Shu-Chen Liu * Leukemia inhibitory factor suppresses functions of macrophages through YAP1 inactivation in oral squamous cell carcinoma (2023/8/18~8/19, 化學生物學及藥物開發研討會研討會)
-Tzu-Tung Liu (劉子彤), Yun-Hua Sui (隋昀華), Ngan-Ming Tsang (曾雁明), Kai-Ping Chang (張凱評), Fang-Yu Tsai (蔡芳瑜), Shih-Sheng Jiang (江士昇), Chen-Han Huang (黃貞翰), Shu-Chen Li u(劉淑貞)* Role of Epstein-Barr Viral Products-Containing Exosomes in Regulating Macrophage Polarization and Immune Response (2023/8/18~8/19, 化學生物學及藥物開發研討會研討會).
-Meng-Hsin Lee (李孟昕), Yun-Hua Sui, Tzu-Tung Liu, Shu-Chen Liu* Investigating the Role of Leukemia Inhibitory Factor-Mediated Immune Response of Mast Cells (2023/8/18~8/19, 化學生物學及藥物開發研討會研討會).
-Hsuan-Chung Chen (陳璿仲), Yun-Hua Sui, Tzu-Tung Liu, Shu-Chen Liu* Investigating the Role of Leukemia Inhibitory Factor Receptor in Cancer Stemness of Oral Squamous Cell Carcinoma (2023/8/18~8/19, 化學生物學及藥物開發研討會研討會).
-- Shu-Chen Liu*, Yun-Hua Sui, Tzu-Tung Liu. The multifaceted roles of leukemia inhibitor factor in tuning the immune microenvironment of oral squamous cell carcinoma. The 27th Taiwan Joint Cancer Conference (第二十七屆台灣癌症聯合學術年會 (2023/5/6-7). (優良論文獎)
-- Yun-Hua Sui, Tzu-Tung Liu, and Shu-Chen Liu *. Leukemia Inhibitory Factor Modulates Macrophage Immune Response Through YAP1 signaling in Oral Squamous Cell Carcinoma. The 27th Taiwan Joint Cancer Conference (第二十七屆台灣癌症聯合學術年會 (2023/5/6-7)
-- Yun-Hua Sui, Tzu-Tung Liu, and Shu-Chen Liu *. Leukemia inhibitory factor regulates macrophage immune response in head and neck squamous cell carcinoma. American Association of Cancer Research (AACR) Annual Meeting (Orlando, FL 32819, United States, 2023/4/14-19)
-- Tzu-Tung Liu, Yun-Hua Sui, Fang-Yu Tsai, Shih-Sheng Jiang, Chen-Han Huang, Shu-Chen Liu*. EBV positive NPC-derived exosomes promote macrophage M2 polarization via activating MST1R signaling. The 27th Taiwan Joint Cancer Conference (第二十七屆台灣癌症聯合學術年會 (2023/5/6-7).(獲優良論文獎)
--Tzu-Tung Liu, Yun-Hua Sui, Kai-Ping Chang, Fang-Yu Tsai, Shih-Sheng Jiang, Chen-Han Huang, Shu-Chen Liu*. EBV positive NPC-derived exosomes promote macrophage M2 polarization via activating MST1R and YAP1 signalings. American Association of Cancer Research (AACR) Annual Meeting (Orlando, FL 32819, United States, 2023/4/14-19).
--Tzu-Tung Liu, Yun-Hua Sui, Kai-Ping Chang, Chen-Han Huang*, Shu-Chen Liu* NPC-Derived Exosomal LMP1 Promotes Macrophage M2 Polarization Via Activating MST1R Signaling. 第37屆生物醫學聯合學術會議(2023/03/18-19)(永信李天德醫藥基金會壁報論文優等獎)
--Yun-Hua Sui, Tzu-Tung Liu, and Shu-Chen Liu*Leukemia Inhibitory Factor Enhances Antitumor Polarization and Oral Squamous Cell Carcinoma Progression in Tumor-Associated Macrophages. 2023 The 37th Joint Annual Conference of Biomedical Sciences第37屆生物醫學聯合學術會議(2023/03/18-19).
--Tzu Tung Liu, Ngan Ming Tsang, Fang Yu Tsai, Shih Sheng Jiang, Shu Chen Liu*(2022, Dec). Systemic Immune Signatures Associated with Radiation Therapy in Nasopharyngeal Carcinoma at Single-Cell Resolution. 22nd Asia-Oceania Congress on Medical Physics (AOCMP) Best Oral Award (Best oral presentation award) (第22屆亞太區醫學物理學會國際學術研討會 最佳口頭論文報告獎).
-- Tzu-Tung Liu, Yun-Hua Sui, Kai-Ping Chang, Fang-Yu Tsai, Shih-Sheng Jiang, Chen-Han Huang, Shu-Chen Liu* NPC-derived exosomal EBV-encoded LMP1 promotes macrophage M2 polarization via activating MST1R signaling. FISS 2023, Formosa Immunology Spring School & Symposium (2023.3.13-17)(福爾摩沙免疫春季學校與會議)
--Yun-Hua Sui, Tzu-Tung Liu, Po-Ju Lee, and Shu-Chen Liu¹ * Leukemia Inhibitor Factor Promotes Polarization and Immune Regulations of Tumor-Associated Macrophages in Oral Squamous Cell Carcinoma. 2022 The 26th Taiwan Joint Cancer Conference, Taipei, Taiwan ((第二十六屆台灣癌症聯合學術年會, 2022,4/30-5/1)
--Tzu-Tung Liu, Yun-Hua Sui, Po-Ju Lee, Chen-Han Huang*, Shu-Chen Liu* Investigating the Role of NPC-Derived Exosomes in Regulating Macrophage Immunity. 2022 The 26th Taiwan Joint Cancer Conference, Taipei, Taiwan ((第二十六屆台灣癌症聯合學術年會, 2022,4/30-5/1)
--Tzu-Tung Liu, Yun-Hua Sui, Po-Ju Lee, Shu-Chen Liu*, Chen-Han Huang*. Nasopharyngeal Carcinoma-Derived EBV Products-Containing Exosomes Regulate Macrophage Polarization and Immune Responses. 2022 The 36th Joint Annual Conference of Biomedical Science (2022 第36屆生物醫學聯合學術年會, 2022, 3/26-3/27)
--Yun-Hua Sui, Tzu-Tung Liu, Po-Ju Lee, Shu-Chen Liu1* (2022, Jan). LIF Regulates Macrophage Immune Response in Oral Squamous Cell Carcinoma. The 28th Symposium on Recent Advances in Cellular and Molecular Biology, Kaohsiung, Taiwan. (第28屆細胞及分子生物新知研討會, 2022, 1/14-16).
--Tzu-Tung Liu, Yun-Hua Sui, Po-Ju Lee, Chen-Han Huang*, Shu-Chen Liu*. Role of EBV Products-Containing Exosomes in Regulating Macrophage Polarization and Immune Response. 2022 The 28th Symposium on Recent Advances in Cellular and Molecular Biology. (2022 第28屆細胞及分子生物新知研討會, 2022, 1/14-1/16).
--Po-Ju Lee, Yun-Hua Sui, Chen-Han Huang, Tzu-Tung Liu, Ngan-Ming Tsang, Shu-Chen Liu*. EBV Products-Containing Exosomes Remodel the Tumor Microenvironment by Activating Stromal Fibroblasts. 2021 The 25th Taiwan Joint Cancer Conference, Taipei, Taiwan (第二十五屆台灣癌症聯合學術年會, 2021,9/4-9/5) (優秀論文獎).
--Yun-Hua Sui, Tzu-Tung Liu, Po-Ju Lee, Shu-Chen Liu1* (2021, Nov). LIF Regulates Macrophage Immune Response in Oral Squamous Cell Carcinoma. 2021 NHRI-NCU Joint Conference, Taoyuan, Taiwan. (2021國衛院-中央聯合學術研討會, 2021, 11/5).
--Tzu-Tung Liu, Yun-Hua Sui, Po-Ju Lee, Shu-Chen Liu*. Investigating the NPC-derived Exosomes-Mediated Effects on Macrophage Polarization and Immune Response. 2021 The 25th Taiwan Joint Cancer Conference, Taipei, Taiwan (第二十五屆台灣癌症聯合學術年會, 2021,9/4-9/5).
--Yun-Hua Sui, Tzu-Tung Liu, Po-Ju Lee, Shu-Chen Liu*.LIF Regulates Macrophage Immune Response in Oral Squamous Cell Carcinoma. 2021 The 25th Taiwan Joint Cancer Conference, Taipei, Taiwan (第二十五屆台灣癌症聯合學術年會, 2021,9/4-9/5).
--Lee PJ, Sui YH, Liu TT, Cai CH, Liu SC* (2020, Mar). EBV+-Nasopharyngeal Cancer-Derived Exosomes Regulate Function of Stromal Fibroblasts. EACR-AACR-ASPIC ‘Basic and Translational Research Conference Tumor Microenvironment, Lisbon, Portugal.
--Lee PJ and Liu SC*. SRC-YAP1 Signaling Modulates Activation of Fibroblasts in the NPC Tumor Microenvironment. The 8th International Conference on Tumor Microenvironment: Progression, Therapy & Prevention. Lisbon, Portugal (2018, June10-14).
--Kao MZ, Lee PJ, Chung MC, Chen CC* and Liu SC*. Magnet Halbach Arrays Induce Cell Cycle Redistribution of Cancer Cells. The 8th International Conference on Tumor Microenvironment: Progression, Therapy & Prevention. Lisbon, Portugal (2018, June10-14).
--PJ and Liu SC*. The potential role of YAP1 protein in AZD0530-mediated suppression of human fibroblast activation (The 23rd Taiwan Joint Cancer Conference, 2018/5/5~6).